Skip to main content
. 2024 Feb 13;25(3):1055–1074. doi: 10.1038/s44319-024-00092-y

Figure EV5. TGF-β promotes IFT88 degradation during LX-2 cell activation.

Figure EV5

(A, B) Immunofluorescence images (A) and quantification of the density of cilia (B) in LX-2 cells treated with TGF-β for 24 h (n  =  6 independent experiments). To quantify the percentage of ciliated cells (B), >140 cells were analyzed for each experiment. Scale bar, 10 µm. (C) IFT88 mRNA expression was measured by quantitative RT-PCR after TGF-β treatment for 24 h in LX-2 cells (n = 3 independent experiments). (DF) Immunoblotting (D) of IFT88 and α-SMA in LX-2 cells treated with TGF-β, and the levels of IFT88 (E) and α-SMA (F) were quantified by densitometry (n = 3 independent experiments). (G, H) The effect of TGF-β on the half-life of IFT88 in LX-2 cells treated with CHX (20 mg/mL) was examined by immunoblotting (G), and the protein half-life curves were obtained (H) (n = 3 independent experiments). (I, J) LX-2 cells were treated with TGF-β for 24 h and then treated with MG132 (5 mM) for 12 h. The levels of IFT88 and GAPDH were examined by immunoblotting (I), and the level of IFT88 was determined by densitometry (J) (n = 3 independent experiments). Data information: Data are presented as mean ± SD. Statistical significance was determined by one-way ANOVA with post hoc tests (E, F) or unpaired two-tailed Student’s t test (B, C, H, J). ns not significant; *P < 0.05, **P < 0.01, ***P < 0.001. Related to Fig. 3. Source data are available online for this figure.